The landscape of genetics and biomarkers in bladder cancer

  • Michael Rink
  • Published 2017 in Translational andrology and urology

Abstract

tau.amegroups.com © Translational Andrology and Urology. All rights reserved. Urothelial carcinoma of the bladder (UCB) is the second most common urological malignancy and ranking among the top ten malignancies in men and women, respectively (1). At initial presentation, the majority of patients have non muscle-invasive bladder cancer (NMIBC), but some… (More)
DOI: 10.21037/tau.2017.11.12

Topics

Cite this paper

@inproceedings{Rink2017TheLO, title={The landscape of genetics and biomarkers in bladder cancer}, author={Michael Rink}, booktitle={Translational andrology and urology}, year={2017} }